Filing Details
- Accession Number:
- 0001140361-12-053145
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-31 16:09:48
- Reporting Period:
- 2012-12-27
- Filing Date:
- 2012-12-31
- Accepted Time:
- 2012-12-31 16:09:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
350907 | Thoratec Corp | THOR | Electromedical & Electrotherapeutic Apparatus (3845) | 942340464 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1354228 | Aaron David Lehman | 6035 Stoneridge Drive Pleasanton CA 94588 | Svp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-12-27 | 4,400 | $17.91 | 47,765 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2012-12-27 | 4,375 | $20.34 | 52,140 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-12-27 | 8,775 | $37.41 | 43,365 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-12-27 | 4,400 | $0.00 | 4,400 | $17.91 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-12-27 | 4,375 | $0.00 | 4,375 | $20.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
16,000 | 2008-02-13 | 2017-02-13 | No | 4 | M | Direct |
0 | 2007-02-24 | 2016-02-24 | No | 4 | M | Direct |
Footnotes
- Options were granted pursuant to the Company's equity incentive plan with no payments received for the options.
- Options vest in four equal annual installments commencing one year after the grant date.
- Options vest 100% one year after the grant date.
- Options exercised and shares of Common Stock sold pursuant to a Sales Plan established by the Reporting Person on November 26, 2012, which Sales Plan is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended.
- This transaction was executed in multiple trades in prices ranging from $37.11 to $37.61. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.